Soriano, Honey M.
HRN: 27-93-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2025
10/20/2025
IV
500 MG
Q8HRS
PARTIAL INTESTINAL OBSTRUCTION
Checking Final Appropriateness